User satisfaction with a smartphone-compatible, artificial intelligence-based cutaneous pigmented lesion evaluator

Chin, Yen Po Harvey; Huang, I‐Hsin; Hou, Ze Yu; Chen, Po Yu; Bassir, Fatima; Wang, Hsiao Han; Lin, Yu Ting; Li, Yu-Chuan

doi:10.1016/j.cmpb.2020.105649

Cited by 6 publications

(16 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a recent study of MoleMe, an AI cutaneous pigment evaluator developed in Taiwan, 90% of participants showed satisfaction with the app. This satisfaction was consistent across varying genders and age groups [65]. If combined with success in improving technologic healthcare equity, smartphone apps incorporating dermatologic AI could be groundbreaking in the diagnosis and care of patients via TD.…”

Section: Looking Forward: Teledermatology In a Post-covid-19 Worldmentioning

confidence: 57%

Teledermatology During COVID-19: An Updated Review

2021

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has fundamentally transformed the landscape of providing dermatologic care. In an age of lockdowns and social distancing, teledermatology (TD) has emerged as a powerful tool to deliver remote care. Here, we review literature on TD use during the pandemic to evaluate the positives and negatives of TD implementation. We especially consider the reception of TD in underserved communities and the developing world as well as the ethico-legal challenges wrought by the burgeoning utilization of this new paradigm of care. The potential of TD to occupy a more prominent role in dermatologic care in a post-COVID-19 world is also discussed.

show abstract

Section: Looking Forward: Teledermatology In a Post-covid-19 Worldmentioning

confidence: 57%

Teledermatology During COVID-19: An Updated Review

2021

View full text Add to dashboard Cite

show abstract

“…Nine reviews [22][23][24][25][28][29][30]36,38] and one systematic review [32]; • Twenty-five papers [21,26,27,31,[33][34][35][40][41][42][43][44][45]48,[50][51][52][53][54][55][56][57][58][59][60].…”

Section: Resultsmentioning

confidence: 99%

“…The search provided 40 components [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ] in the three years since the COVID-19 pandemic outbreak (at the date of this study).…”

Section: Resultsmentioning

confidence: 99%

“…In detail, the components were: Two randomized controlled (clinical) trials (RCTs) [ 37 , 49 ]; Three observational studies (OS)s [ 39 , 46 , 47 ]; Nine reviews [ 22 , 23 , 24 , 25 , 28 , 29 , 30 , 36 , 38 ] and one systematic review [ 32 ]; Twenty-five papers [ 21 , 26 , 27 , 31 , 33 , 34 , 35 , 40 , 41 , 42 , 43 , 44 , 45 , 48 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ]. …”

Section: Resultsmentioning

confidence: 99%

“…Twenty-five papers [ 21 , 26 , 27 , 31 , 33 , 34 , 35 , 40 , 41 , 42 , 43 , 44 , 45 , 48 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ].…”

Section: Resultsunclassified

See 2 more Smart Citations

Advancing Dermatological Care: A Comprehensive Narrative Review of Tele-Dermatology and mHealth for Bridging Gaps and Expanding Opportunities beyond the COVID-19 Pandemic

Giansanti

2023

Healthcare

View full text Add to dashboard Cite

Mobile health (mHealth) has recently had significant advances in tele-dermatology (TD) thanks to the developments following the COVID-19 pandemic. This topic is very important, as telemedicine and mHealth, when applied to dermatology, could improve both the quality of healthcare for citizens and the workflow in the health domain. The proposed study was centered on the last three years. We conducted an overview on the opportunities, the perspectives, and the problems involved in TD integration with mHealth. The methodology of the narrative review was based on: (I) a search of PubMed and Scopus and (II) an eligibility assessment, using properly proposed parameters. The outcome of the study showed that during the COVID-19 pandemic, TD integration with mHealth advanced rapidly. This integration enabled the monitoring of dermatological problems and facilitated remote specialist visits, reducing face-to-face interactions. AI and mobile apps have empowered citizens to take an active role in their healthcare. This differs from other imaging sectors where information exchange is limited to professionals. The opportunities for TD in mHealth include improving service quality, streamlining healthcare processes, reducing costs, and providing more accessible care. It can be applied to various conditions, such as (but not limited to) acne, vitiligo, psoriasis, and skin cancers. Integration with AI and augmented reality (AR), as well as the use of wearable sensors, are anticipated as future developments. However, integrating TD with mHealth also brings about problems and challenges related to regulations, ethics, cybersecurity, data privacy, and device management. Scholars and policymakers need to address these issues while involving citizens in the process.

show abstract

Analysis of skin health management through telemedicine and mobile health in dermatology in the post-COVID era

Gençoğlu

2024

Eur Res J

View full text Add to dashboard Cite

Mobile health has made significant strides in the field of tele-dermatology (TD) following the developments post the COVID-19 pandemic. The application of telemedicine and mobile health to dermatology holds the potential to enhance the quality of healthcare for citizens and streamline workflows in the healthcare domain, hence this subject is of great importance. This research encompasses the last three years. A comprehensive overview examining the opportunities, perspectives, and encountered challenges regarding the integration of TD with mHealth has been provided. The narrative review methodology is based on (I) conducting research via PubMed and Scopus, and (II) conducting compliance assessment using the proposed parameters. The outcome of the research indicates rapid progress in the integration of TD with mobile health during the COVID-19 pandemic. This integration has facilitated the monitoring of dermatological issues and allowed for remote specialist visits, thereby reducing face-to-face interactions. Artificial intelligence and mobile applications have empowered citizens to take a more active role in their own healthcare, which is distinct from other imaging areas where information exchange is limited only to professionals. Opportunities that TD can offer in the field of mobile health include enhancing service quality, increasing the efficiency of healthcare processes, reducing costs, and providing more accessible care. This is applicable not only to conditions like acne, vitiligo, psoriasis, and skin cancers but also to other conditions. Integration with artificial intelligence and augmented reality (AR), along with the use of wearable sensors, are expected as future developments. However, the integration of TD with mobile health brings along issues and challenges related to regulation, ethics, cybersecurity, data privacy, and device management. These issues, along with the involvement of citizens in the process, should be addressed by scientists and policymakers.

show abstract

User satisfaction with a smartphone-compatible, artificial intelligence-based cutaneous pigmented lesion evaluator

Cited by 6 publications

References 47 publications

Teledermatology During COVID-19: An Updated Review

Teledermatology During COVID-19: An Updated Review

Advancing Dermatological Care: A Comprehensive Narrative Review of Tele-Dermatology and mHealth for Bridging Gaps and Expanding Opportunities beyond the COVID-19 Pandemic

Analysis of skin health management through telemedicine and mobile health in dermatology in the post-COVID era

Contact Info

Product

Resources

About